Instrument Inactif

Autres langues Antares

Actions

ANT

BE0003676872

Services de placements diversifiés

Autres langues

07/03/22	Antares : utile netto adj. 2021 cresce a 28,3 mln (24,7 mln in 2020)
07/03/22	L'agenda di oggi
04/03/22	L'agenda della prossima settimana
03/03/22	Antares : sospende periodo esercizio conversione dei Warrant
03/03/22	Antares Pharma Posts Higher Q4 Adjusted Earnings, Revenue; Issues 2022 Revenue Guidance
03/03/22	Earnings Flash (ATRS) ANTARES PHARMA Posts Q4 EPS $0.02, vs. Street Est of $0.01
03/03/22	Earnings Flash (ATRS) ANTARES PHARMA Reports Q4 Revenue $48.7M, vs. Street Est of $47.2M
24/02/22	Immo-Antares NV Reports Earnings Results for the Full Year Ended November 10, 2021
18/02/22	Antares : perfeziona acquisizione Acsis per 12 mln usd
18/02/22	Antares Vision Closes Acquisition Of US Software Firm ACSIS
14/02/22	Antares : accordo per acquisire Acsis
03/02/22	Antares Pharma's New Drug Application Resubmission for Testosterone Replacement Therapy Receives FDA Acceptance
02/02/22	Antares Vision : nuovo capitale sociale pari a 169.452 euro
25/01/22	Antares V. : Applied Vision scelta per installazioni in Turchia
18/01/22	Antares Pharma Secures FDA Fast Track Designation for ATRS-1902 in Acute Adrenal Insufficiency
18/01/22	Antares Gets FDA Fast-Track Designation for ATRS-1902 for Adrenal Crisis Rescue
11/01/22	Antares Pharma Says its Early-Stage Study of ATRS-1902 for Acute Adrenal Insufficiency Met its Primary Objective
30/12/21	Borsa I. : 2021 è anno record con 49 Ipo
16/12/21	Assertio Therapeutics Acquires Otrexup from Antares Pharma for $44 Million
08/12/21	Exclusive-Canada's CPP Investments seeks to sell insurance groups in strategy U-turn -sources
18/11/21	Hogere huurinkomsten voor Inclusio dan voorzien
12/11/21	Antares Vision : 3* trim. ricavi pari a 44 mln (+24% a/a)
12/11/21	L'agenda di oggi
10/11/21	Economia : premio eccellenze d'impresa, Zucchetti vincitore assoluto fra 150 aziende
10/11/21	L'agenda della settimana